Navigation Links
Princess by proxy: When child beauty pageants aren't about the kids
Date:10/26/2012

ips, puppies or even movie "bit parts." The potential for fame and fortune, Cartwright says, may contribute to "achievement by proxy distortion" in parents.

It is not uncommon for parents, especially those of young athletes, to exhibit what is known as benign "achievement by proxy," in which they experience pride and joy through their child's achievements but still recognize a child's limitations, says Cartwright, who has worked extensively with young athletes and dancers as a dietician.

"Achievement by proxy distortion," however, occurs when parents struggle to differentiate between their own need and their child's needs, and in order to achieve what they perceive as success, they may engage in risky behaviors, objectification or even abuse and exploitation of a child, elements of which Cartwright said she witnessed at the glitz pageants she attended.

"I think it's fun if they want to play dress up for a little while, but to insist on making that a career or that they're going to be a model or a Hollywood star, the chances are very slim," she said in an interview. "Parents have to know their child's limitations and not pres them beyond that because later on that knocks their self esteem."

Cartwright said she talked with pageant parents who made risky financial investments to support their child's participation, spending above and beyond the amount of the contest's top prize. She also witnessed parents putting high pressure on their young daughters to look "flawless" and win at all costs, pushing them to adopt an unnatural and adult-like physical appearance and chastising them for poor performance, lack of enthusiasm or a flawed appearance.

"Everything was based on what these kids look like and the way that these children were displayed or dressed," Cartwright said. "They were fully made up; they looked like adult women, pint-size. They were judged on personality, but none spoke a word."

The emphasis on physical
'/>"/>

Contact: Martina Cartwright
drmartinac@mac.com
480-399-0270
University of Arizona
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. A mother’s nutrition--before pregnancy--may alter the function of her children’s genes
2. Wayne State receives $2.8 million grant from US Administration for Children and Families
3. Genetic make-up of children explains how they fight malaria infection
4. Older overweight children consume fewer calories than their healthy weight peers
5. New equipment is breath of fresh air for childrens lung researchers
6. Limiting TV time -- Effective strategy for preventing weight gain in children
7. Antibiotic use in infants before 6 months associated with being overweight in childhood
8. Vitamin D supplementation can decrease risk of respiratory infections in children
9. School food -- on the front line in the fight against childhood obesity
10. Childrens physical activity levels are not enough to counteract sedentary lifestyles
11. When do German children gain weight?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... OXFORD, Conn. , Apr. 27, 2015 ... "Company"), a biometric authentication company focused on the growing ... will commence shipping to pre-order customers the first week ... pre-orders through the month of May. ... is a significant milestone for the company as Wocket® ...
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
... While many bacteria exist as aggressive pathogens, causing diseases ... toxic shock syndrome, others play a less malevolent role ... a new study, Cheryl Nickerson and her group at ... including Tom Van de Wiele and lead author Rosemarie ...
... , adds to our understanding of the role of stem and ... and treatment of cancer. , While stem cells are known to ... difficult to isolate. The new findings show that an antibody developed ... , Professor Pera, program leader for Stem Cells Australia and Chair ...
... Manchester have uncovered how the internal mechanisms in nerve ... avenues in the investigation of neurodegenerative diseases by analysing ... Prokop and his team at the Faculty of Life ... thin cable-like extensions of nerve cells that wire the ...
Cached Biology News:Beneficial bacteria may help ward off infection 2Beneficial bacteria may help ward off infection 3Beneficial bacteria may help ward off infection 4Beneficial bacteria may help ward off infection 5Stem cell research aids understanding of cancer 2Cell research opens new avenues in combating neurodegenerative diseases 2Cell research opens new avenues in combating neurodegenerative diseases 3
(Date:5/1/2015)... Md. and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Roger Jeffs , ... provide an overview and update on the company,s business at ... in Boston, Massachusetts . The ... 3:30 PM Eastern Time, and can be accessed via a ...
(Date:4/30/2015)... 30, 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... testing solutions for the detection of foodborne pathogens, announced ... quarter of 2015 on May 7, 2015 after the ... will also host a conference call at 4:30 p.m. ... first quarter financial results. During the conference call, material ...
(Date:4/30/2015)... (PRWEB) April 30, 2015 Cytokinetics, Incorporated (Nasdaq: ... quarter of 2015 were $4.4 million, compared to $8.0 million ... for the first quarter was $8.9 million, or $0.23 per ... loss for the same period in 2014, of $8.7 million, ... March 31, 2015, cash, cash equivalents and investments totaled $117.5 ...
(Date:4/30/2015)... Nitto Avecia, a leading biotechnology manufacturer ... and production capability to serve biotechnology pharmaceutical clients. ... fulfillment continues to drive Nitto Avecia to enhance ... , In Fall 2014, Nitto Avecia ... at its Milford, MA facility, which is recognized ...
Breaking Biology Technology:Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... Oct. 5 ISTO Technologies, Inc. (ISTO), an  orthobiologics ... today the completion of patient enrollment in the Phase ... formulation of juvenile chondrocytes designed for the treatment of ... at two clinical sites. All patients enrolled in the ...
... the many pressing concerns of the day, fear of plague ... for those whose responsibility it is to combat bioterrorism, plague ... include scientists like medical researcher Steve Smiley, whose lab at ... will protect the public against weaponized forms of plague. The ...
... AMGN ) today announced that results from ... evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX or ... colorectal cancer (mCRC), respectively, were published online in the ... "Both studies demonstrated that Vectibix administered with chemotherapy significantly ...
Cached Biology Technology:ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial 2ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial 3Plague researchers race to beat bioterrorists 2Plague researchers race to beat bioterrorists 3Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 2Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 3Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 4Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 5Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 6Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 7Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 8Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 9Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 10Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 11
Agar, 500 g. Noble Agar.Moisture: < 10%, ash: < 1.6%, EEO (-mr): < 0.450 (pH 8.4). Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
MW5...
From micro to giga sizes, from single prep to high-throughput, Invitrogen's range of plasmid purification kits offers superior performance to match the demands of your downstream application....
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient...
Biology Products: